Pre-Activity Self-Assessment: https://www.surveymonkey.com/r/8N7JNKK |
EDUCATIONAL NEEDS Hospital-acquired bacterial pneumonia (HABP) and ventilator-associated bacterial pneumonia (VABP) continue to be associated with poor clinical outcomes despite continued advances in prevention and management. For critically ill patients, long-term outcomes are especially poor with high rates of in-hospital and 30-day mortality. Further complicating management decisions has been the emergence of the COVID-19 pandemic. Emerging data is demonstrating that up to a third of COVID-19 patients have a secondary infection, with bacterial superinfection or coinfection more likely in patients with severe illness. ICU COVID-19 patients with prolonged hospitalization and/or intubation are also at greater risk of infection with multidrug-resistant (MDR) Gram-negative bacteria, likely reflecting hospital-acquired infection. Patient outcomes are closely linked to timely and appropriate initial therapy. Evidence-based strategies have been identified to help improve long-term outcomes of HABP/VABP patients. These include the use of antibiograms, rapid diagnostics, and newer antimicrobials. Maximizing the potential of these tools requires ID clinicians to be fully competent on their use in clinical practice in order to tailor management approaches based on patient factors and needs. This program is designed to build competence, confidence, and skills in the management of HABP/VABP while increasing the understanding of how to utilize the latest tools as part of antimicrobial stewardship efforts.
LEARNING OBJECTIVES At the conclusion of the educational activity, the learner should be able to:
|
TARGET AUDIENCE This continuing medical education activity meets the needs of healthcare providers in a variety of practice settings, including large and small health systems, outpatient clinics, managed-care organizations, long-term care facilities, and academia. This activity would be especially beneficial for ID physicians and pharmacists who are on the frontline of managing patients with serious bacterial infections.
FACULTY
|
| ||||
Accreditation This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of Center for Independent Healthcare Education (Center) and Vemco MedEd. Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Physician Assistants Nurse Practitioners Pharmacists For questions regarding the accreditation of this activity, please contact us at info@jointsponsor.com
Method of Participation and Instruction for Credit
Disclosure of Conflicts of Interest In accordance with policies set forth by the Accreditation Council for Continuing Medical Education (ACCME), Center for Independent Healthcare Education requires all faculty members and spouses/significant others with an opportunity to affect the content of a continuing education activity to disclose any relevant financial relationships during the past 12 months with commercial interests. A commercial interest is any entity producing, marketing, reselling or distributing health care goods or services consumed by or used on patients. Relationships with commercial interests and conflicts of interest resulting from those relationships must be revealed to the audience and resolved prior to the activity.Relevant relationships include roles such as speaker, author, consultant, independent contractor (including research), employee, investor, advisory committee member, board member, review panelist, and investigator. If a potential speaker or author indicates a possible conflict of interest, the conflict will be resolved by choosing another speaker or author for that topical area, or the slides, handouts, and/or monograph will be reviewed and approved by a qualified commercially-disinterested peer. |
Disclosures
Edward Septimus, MD does not have relevant financial relationships with commercial interests.
George Karam, MD has relevant financial relationships with the following commercial interests:
Marin Kollef, MD has relevant financial relationships with the following commercial interests:
Melissa Johnson, PharmD has relevant financial relationships with commercial interests:
No (other) speakers, authors, planners or content reviewers have any relevant financial relationships to disclose. Fee Hardware/Software Requirements Software/Hardware Connection Speed System Check Copyright Statement Privacy Policy Joint Providership Commercial Support This activity is supported by an educational grant from Merck & Co., Inc. |
|
|